FEBS Letters · 2006 · 46 citations · 21 references
Life SciencesCell BiologyOncologyApoptosisChemotherapyMolecular Cell BiologyApoptosis In CancerApoptosis RegulationApoptotic SignalingBcl-2 Family ProteinsIntrinsic Apoptotic PathwayMitochondrial ToxicityApoptosis InductionChemotherapy-induced ApoptosisGenotoxic Stress ResponseMitochondrial Apoptosis PathwaysMitochondrial Apoptosis RegulationMitochondrial Apoptosis SignalingMitochondrial Apoptotic SignalingMitochondrial Pathway Of Apoptosis
Doxorubicin, cis-diamminedichloroplatinum (II) and 5-fluorouracil used in chemotherapy induce apoptosis in Hep3B cells in the absence of p53, p73, and functional Fas. Since mediators remain unknown, the requirement of PKC delta (PKCdelta) and c-Abl was investigated. Suppression of c-Abl or PKCdelta expression using SiRNAs impaired PARP cleavage, Gleevec and/or rottlerin inhibited the induction of the subG1 phase and the increase of reactive oxygen species level. Co-precipitations and phosphorylations to mitochondria of c-Abl, PKCdelta and Bcl-X(L/s) were induced. A depolarization of the mitochondrial membrane and activations of caspase-2 and -9 were observed. We propose that, in the absence of p53, p73 and Fas, genotoxic drugs could require both PKCdelta and c-Abl to induce apoptosis through the mitochondrial pathway.
21
Luowei Li, Patricia S. Lorenzo, Krisztina Bögi et al. · Molecular and Cellular Biology · 1999 · 279 citations · Full text